CEN Case Reports

, Volume 7, Issue 1, pp 13–16 | Cite as

Relapse of nephrotic syndrome triggered by Kawasaki disease

  • Ryo Maeda
  • Yukihiko Kawasaki
  • Shigeo Suzuki
  • Shinichiro Ohara
  • Suyama Kazuhide
  • Mitsuaki Hosoya
Case Report
  • 68 Downloads

Abstract

Minor infections, allergies, insect bites, and bee stings are commonly reported causes of nephrotic syndrome (NS). Herein, we report, to the best of our knowledge, the first case of NS relapse due to Kawasaki disease (KD). An 8-year-old boy presented with high fever of 4-day duration. He had developed steroid-dependent NS at the age of 4 years and remained in remission after steroid and mizonbin therapy. Renal biopsy, performed at the age of four, showed minimal change (MC) disease. Upon examination, the patient fulfilled 5 of 6 criteria for KD under the Japanese diagnostic guidelines, with positive proteinuria. He was diagnosed with NS relapse caused by KD. Proteinuria resolved after treatment with intravenous immunoglobulin and cyclosporine A. We present the case of an 8-year-old boy, whose NS relapsed due to KD. To the best of our knowledge, this is the first case report. It is necessary to recognize that KD can trigger relapse of MCNS.

Keywords

NS MCD Relapse Kawasaki disease Cyclosporine A Intravenous immunoglobulin 

Notes

Compliance with ethical standards

Conflict of interest

All the authors have declared that no conflict of interest exists.

Human and animal rights statement

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Asadi-Pooya AA, Borzoee M, Amoozgar H. The experience with 113 patients with Kawasaki disease in Fars Province, Iran. Turk J Pediatr. 2006; 48: 109–14.Google Scholar
  2. 2.
    Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA. Committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American heart association: diagnosis, treatment and long-term management in Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease in the young, American heart association. Pediatrics. 2004;114:1708–33.CrossRefPubMedGoogle Scholar
  3. 3.
    Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T cell function. Lancet. 1979;7:556–60.Google Scholar
  4. 4.
    Krug P, Boyer O, Balzamo E, Sidi D, Lehnert A, Niaudet P. Nephrotic syndrome in Kawasaki disease: a report of three cases. Pediatr Nephrol. 2012;27:1547–50.CrossRefPubMedGoogle Scholar
  5. 5.
    Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017;12:332–45.CrossRefPubMedGoogle Scholar
  6. 6.
    Sanchez-Niño MD, Bentio-Martin A, Gonoçalves S, Sanz AB, Ucero AC, Izquierdo MC, Ramos AM, Berzal S, Selgas R, Ruiz-Ortega M, Egido J, Ortis A. TNF superfamily: a growing saga of kidney injury modulators. Mediat Inflamm.  https://doi.org/10.1055/2010/182958.
  7. 7.
    Brähler S, Ising C, Aranda BB, Höhne M, Schermer B, Benzing T, Brinkkoetter PT. The NF-κB essential modulator (NEMO) controls podocyte cytoskeletal dynamics independently of NF-κB. Am J Physiol Renal Physiol. 2015;309:617–26.CrossRefGoogle Scholar
  8. 8.
    Brogan PA, Bose A, Burgner D, Shingadia D, Tulloh R, Michie C, Klein N, Booy R, Levin M, Dillon MJ. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child. 2002;86:286–90.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Nardi PM, Haller JO, Friedman AP, Slovis TL, Schaffer RM. Renal manifestations of Kawasaki’s disease. Pediatr Radiol. 1985;15:116–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Watanabe T, Abe Y, Sato S, Uehara Y, Ikeno K, Abe T. sterile pyuria in patients with Kawasaki disease originates from both the urethra and the kidney. Pediatr Nephrol. 2007;22:987–91.CrossRefPubMedGoogle Scholar
  11. 11.
    Maji B, Banerjee S, Pal P. Nephrotic syndrome in Kawasaki disease. Clin Pediatr. 2014;53(9):898–9.CrossRefGoogle Scholar
  12. 12.
    Leung DY, Geha RS, Newburger JW, Burns JC, Fiers W, Lapierre LA, Pober JS. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med. 1986;164(6):1958–72.CrossRefPubMedGoogle Scholar
  13. 13.
    Kidney Disease Improving Global Outcomes Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int 2(Suppl. 2):163–71.Google Scholar
  14. 14.
    Suzuki N, Seguchi M, Kouno C, Inukai K, Kito H, Kobayashi H. Rupture of coronary aneurysm in Kawasaki disease. Pediatr Int. 1999;41:318–20.CrossRefPubMedGoogle Scholar
  15. 15.
    Kobayashi T, IInoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113:2606–12.CrossRefPubMedGoogle Scholar
  16. 16.
    Lee J, Kim GB, Kwon BS, Bae EJ, Noh CI. Two cases of super-giant coronary aneurysms after Kawasaki disease. Korean Circ J. 2014;44:54–8.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2017

Authors and Affiliations

  • Ryo Maeda
    • 1
    • 2
  • Yukihiko Kawasaki
    • 1
  • Shigeo Suzuki
    • 2
  • Shinichiro Ohara
    • 1
  • Suyama Kazuhide
    • 1
  • Mitsuaki Hosoya
    • 1
  1. 1.Department of PediatricsFukushima Medical University School of MedicineFukushimaJapan
  2. 2.Department of PediatricsOhara General HospitalFukushimaJapan

Personalised recommendations